→
HCA Healthcare Inc's current price of $423 represents a 9.7 point decline, or 2.24% drop from the previous close of $432.7. The stock's P/E ratio of 13.86 indicates it is trading at a discount compared to the industry average, but with a disappointing Q1 2026 earnings miss of $7.15 against an estimate of $7.21, investor sentiment may remain cautious. Furthermore, the notable revenue growth of 6.71% year-over-year is overshadowed by the company's low current ratio of 0.83, reflecting potential liquidity issues.
I recommend avoiding HCA Healthcare Inc stock until clearer signs of operational stability and earnings improvement emerge.
If HCA can leverage its strong EPS growth of 29.19% to improve operational efficiencies, it could regain investor confidence and push its share price back toward the 52-week high of $556.52. Additionally, a robust analyst consensus with 19 out of 30 ratings as Buy or Strong Buy may indicate upside potential in the long term.
The recent earnings miss in Q1 2026, where actual EPS of $7.15 fell short of the estimated $7.21, raises concerns about future profitability. Coupled with a low current ratio of 0.83, which suggests potential liquidity challenges, HCA may struggle to attract new investments in the near term.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates HCA as Bearish. I recommend avoiding HCA Healthcare Inc stock until clearer signs of operational stability and earnings improvement emerge.
The recent earnings miss in Q1 2026, where actual EPS of $7.15 fell short of the estimated $7.21, raises concerns about future profitability. Coupled with a low current ratio of 0.83, which suggests potential liquidity challenges, HCA may struggle to attract new investments in the near term.
If HCA can leverage its strong EPS growth of 29.19% to improve operational efficiencies, it could regain investor confidence and push its share price back toward the 52-week high of $556.52. Additionally, a robust analyst consensus with 19 out of 30 ratings as Buy or Strong Buy may indicate upside potential in the long term.
HCA Healthcare Inc's current price of $423 represents a 9.7 point decline, or 2.24% drop from the previous close of $432.7. The stock's P/E ratio of 13.86 indicates it is trading at a discount compared to the industry average, but with a disappointing Q1 2026 earnings miss of $7.15 against an estimate of $7.21, investor sentiment may remain cautious. Furthermore, the notable revenue growth of 6.71% year-over-year is overshadowed by the company's low current ratio of 0.83, reflecting potential liquidity issues.
HCA Healthcare Inc's current price of $423 represents a 9.7 point decline, or 2.24% drop from the previous close of $432.7. The stock's P/E ratio of 13.86 indicates it is trading at a discount compared to the industry average, but with a disappointing Q1 2026 earnings miss of $7.15 against an estimate of $7.21, investor sentiment may remain cautious. Furthermore, the notable revenue growth of 6.71% year-over-year is overshadowed by the company's low current ratio of 0.83, reflecting potential liquidity issues. Our overall verdict is Bearish.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for HCA at helmterminal.dev/analyze/HCA, updated continuously during US market hours. No signup required.